Apollo Therapeutics is a portfolio biopharmaceutical company focused on translating medical research into medicines.
Apollo Therapeutics has raised $33.5M in total funding. The most recent round was Series C. The last funding was announced in January 2024.
Apollo Therapeutics's investors include Patient Square Capital, Rock Springs Capital, M&G Plc, UCL Technology Fund, Reimagined Ventures.
Apollo Therapeutics is headquartered in Cambridge, United Kingdom.
Apollo Therapeutics is a portfolio biopharmaceutical company focused on translating medical research into medicines.
Apollo Therapeutics is at the Series C stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Apollo Therapeutics — Funding & Investors." VCBacked, January 2, 2024, https://www.vcbacked.co/company/apollo-therapeutics. Accessed August 14, 2026.
VCBacked. (2024). Apollo Therapeutics — Funding & Investors. Retrieved August 14, 2026, from https://www.vcbacked.co/company/apollo-therapeutics
{{cite web |title=Apollo Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/apollo-therapeutics |website=VCBacked |access-date=August 14, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated